Image

Innate Immune Cell Phenotypes and Early Fibrotic Repair in Acute Myocardial Infarction

Innate Immune Cell Phenotypes and Early Fibrotic Repair in Acute Myocardial Infarction

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

To determine the relationship of the phenotypes of neutrophils and monocytes with early fibrotic repair after acute myocardial infarction.

Description

This study will enroll 50 patients with ST-segment elevation myocardial infarction (STEMI). Peripheral blood will be collected from these patients for immune cell subset analysis, serum cytokine evaluation, and neutrophil sorting for transcriptome sequencing. At 1 week after admission, cardiac magnetic resonance (CMR) will be performed to evaluate the myocardial salvage index, area of late gadolinium enhancement (LGE), microvascular obstruction (MVO), extracellular volume (ECV), and left ventricular ejection fraction (LVEF).

Eligibility

Inclusion Criteria:

\---- Age \> 18 and ≤ 80 years old

\- Patients with acute STEMI within 12 hours of symptom onset who are planned to receive PPCI

Exclusion Criteria:

  • Prior revascularization
  • Known allergy to gadopentetate dimeglumine contrast agent
  • Pregnancy or planned pregnancy within the next 6 months
  • Life expectancy \< 1 year
  • Metallic implants or claustrophobia that precluded MRI
  • Severe COPD or inability to hold breath for MRI
  • Severe hepatic or renal dysfunction (ALT \> 5×ULN or eGFR \< 15 mL/min/1.73 m²)

Study details
    Myocardial Infarction

NCT07764588

Shanghai 10th People's Hospital

15 August 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.